Detection of trophoblastic tumour activity by pregnancy-specific beta-1-glycoprotein. 1978

M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall

Pregnancy-specific beta-1-glycoprotein (PSBG) and human chorionic gonagotrophin (hCG) were measured by specific radioimmunoassays in 73 serum samples from eight patients treated for gestational choriocarcinoma. Both markers were initially present in all cases, but at the time of writing both had levelled off in six cases and decreased markedly in two. Usually hCG was detectable for longer than PSBG during the course of chemotherapy. Both PSBG and hCG reappeared on clinical recurrence. However, at times during the follow-up period one trophoblastic marker only was expressed. This was hCG in most cases, but in one case PSBG alone was encountered. These results suggest that PSBG may serve as an additional marker for the detection of residual tumour growth in patients with trophoblastic tumours.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
October 1980, American journal of obstetrics and gynecology,
M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
January 1984, British medical journal (Clinical research ed.),
M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
January 1982, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine,
M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
January 1989, Akusherstvo i ginekologiia,
M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
January 1984, Revista espanola de oncologia,
M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
October 1986, Akusherstvo i ginekologiia,
M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
January 1984, La Ricerca in clinica e in laboratorio,
M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
August 1986, The Indian journal of medical research,
M Seppälä, and E M Rutanen, and M Heikinheimo, and H Jalanko, and E Engvall
November 1987, Zhonghua fu chan ke za zhi,
Copied contents to your clipboard!